Clinical values of two estrogen receptor signaling targeted lncRNAs in invasive ductal breast carcinoma | Zendy

Shahrzad Ilbeigi | Zendy; Yasaman Naeimzadeh | Zendy; Mostafa Davoodabadi Farahani | Zendy; Mohammad Rafiee Monjezi | Zendy; Hassan Dastsooz | Zendy; Abdolreza Daraei | Zendy; Farahnaz Farahani | Zendy; Alireza Dastgheib | Zendy; Yaser Mansoori | Zendy; Kaoru Tabei | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical values of two estrogen receptor signaling targeted lncRNAs in invasive ductal breast carcinoma

Author(s) -

Shahrzad Ilbeigi,

Yasaman Naeimzadeh,

Mostafa Davoodabadi Farahani,

Mohammad Rafiee Monjezi,

Hassan Dastsooz,

Abdolreza Daraei,

Farahnaz Farahani,

Alireza Dastgheib,

Yaser Mansoori,

Kaoru Tabei

Publication year - 2021

Publication title -

klinicka onkologie

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.204

H-Index - 13

eISSN - 1802-5307

pISSN - 0862-495X

DOI - 10.48095/ccko2021382

Subject(s) - downregulation and upregulation , cancer research , breast cancer , biology , ductal carcinoma , cancer , estrogen receptor , invasive ductal carcinoma , medicine , oncology , gene , genetics

Invasive ductal carcinoma (IDC) is the most frequent type of breast cancer (BC) in women, with a high clinical burden due to its high invasive properties. Despite of quickly emerging new data regarding the molecular heterogeneity of invasive cancers, far less is known about the molecular patterns among cases of IDC. An expanding body of evidence has demonstrated that dysregulation of long noncoding RNAs (lncRNAs) is involved in the heterogeneity feature of BC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research